Results 221 to 230 of about 1,208,918 (256)

Allergic bronchopulmonary aspergillosis as an initial manifestation of cystic fibrosis: Diagnostic and therapeutic implications in the era of CFTR modulators. [PDF]

J Allergy Clin Immunol Glob
Mitropoulou G, Balmpouzis Z, Oberhansli-Wavre A, Morris M, Blanchon S, Sauty A, Koutsokera A.   +6 more
europepmc   +1 more source

Comparison of the Effect of CFTR Modulators <i>elexacaftor</i>/<i>tezacaftor</i>/<i>ivacaftor</i> and <i>lumacaftor</i>/<i>ivacaftor</i> via Serum Human Epididymis Protein 4 Concentration in <i>p.Phe508del-CFTR</i> Homozygous Cystic Fibrosis Patients. [PDF]

J Clin Med
Pócsi M, Fila L, Péterfia C, Halász A, Szanto TG, Mészáros B, Major J, Laki I, Szabó H, Panyi G, Balogh I, Amaral MD, Macek M, Nagy B.   +13 more
europepmc   +1 more source

Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis. [PDF]

J Cyst Fibros
Jia S, Wang Y, Ross MH, Zuckerman JB, Murray S, Han MK, Cahalan SE, Lenhan BE, Best RN, Taylor-Cousar JL, Simon RH, Fitzgerald LJ, Troost JP, Sood SL, Gifford AH.   +14 more
europepmc   +1 more source

The Italian external quality assessment program for Cystic Fibrosis sweat chloride test: CFTR modulators and the impact of a new sweat test report form. [PDF]

Pract Lab Med
Cirilli N, Floridia G, Amato A, Padoan R, Censi F, Ferrari G, Raia V, Castaldo G, Capoluongo E, Taruscio D, Salvatore M.   +10 more
europepmc   +1 more source

Clinical outcomes of two infants with cystic fibrosis, including presence of the vas deferens, born to a woman with cystic fibrosis taking CFTR modulators during both pregnancies

Aleksandra Kowalik, Emma Roberts, Anna Hedborg Harris, Marie Sund, Sara Wird, Ola Kvist, L. Hjelte   +6 more
openalex   +1 more source

Erratum: Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators. [PDF]

Am J Respir Crit Care Med
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug-drug interactions involving CFTR modulators: a review of the evidence and clinical implications

Expert Opinion on Drug Metabolism & Toxicology, 2023
Introduction Cystic fibrosis (CF) is characterized by mucus accumulation impairing the lungs, gastrointestinal tract, and other organs. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators (ivacaftor, tezacaftor, elexacaftor, and ...
E. Hong, Alan Shi, P. Beringer
semanticscholar   +1 more source

Upper Airway Disease in Adults with Cystic Fibrosis in the Era of CFTR Modulators

The Laryngoscope, 2023
Chronic rhinosinusitis (CRS) is prevalent in people with cystic fibrosis (PwCF) and is often refractory to treatments. Uncontrolled CRS might negatively impact the lower airways and the quality of life.
S. Uyttebroek, L. Dupont, M. Jorissen, L. Van Gerven   +3 more
semanticscholar   +1 more source